US 11,872,273 B2
Proteins and immunizing compositions containing Klebsiella proteins and methods of use
Douglas T. Burkhardt, Dassel, MN (US); Daryll Emery, New London, MN (US); and Darren Straub, New London, MN (US)
Assigned to Epitopix, LLC, Willmar, MN (US)
Filed by EPITOPIX, LLC, Willmar, MN (US)
Filed on Apr. 9, 2021, as Appl. No. 17/226,761.
Application 17/226,761 is a continuation of application No. 15/741,574, granted, now 11,000,582, previously published as PCT/US2016/041614, filed on Jul. 8, 2016.
Claims priority of provisional application 62/190,947, filed on Jul. 10, 2015.
Prior Publication US 2021/0330776 A1, Oct. 28, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 39/108 (2006.01); A61K 39/116 (2006.01); A61K 39/00 (2006.01); C07K 14/26 (2006.01); A61K 39/40 (2006.01)
CPC A61K 39/0266 (2013.01) [A61K 39/116 (2013.01); A61K 39/40 (2013.01); C07K 14/26 (2013.01); A61K 2039/552 (2013.01)] 5 Claims
 
1. A composition comprising:
an isolated protein comprising an amino acid sequence that has at least 80% identity with SEQ ID NO:41 and an isolated protein comprising an amino acid sequence that has at least 80% identity with SEQ ID NO:43;
an effective amount of an adjuvant; and
a pharmaceutically acceptable carrier.